EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SnRNA ‐seq reveals cellular heterogeneity and proliferation mechanisms in limb venous malformations

Junjie Lin, Tingting Liu, Bin Fang, Xiaojuan Feng, Wenting Jiao, Changkuan Chen, Yaqing Ding, Gaozan Zhu, Wenqiu Wang, Wenbo Liu, Yuanqi Li, Shoufu Hou und 2 weitere

Animal Models and Experimental Medicine · 2026

DOI: 10.1002/ame2.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Junjie Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hemangioma Surgery, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Cell Proliferation, Vascular Malformations, Extremities. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Henan University graduate "Talent Program" of Henan Province of China, Henan Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venous malformations (VMs) are congenital vascular anomalies characterized by abnormal vascular proliferation, with limb VMs often leading to functional impairment and physical discomfort. However, the cellular heterogeneity and underlying molecular mechanisms driving pathological proliferation in limb VMs remain incompletely elucidated.

Methods

In this study, we collected 10 tissue samples including specimens from 5 limb VM patients and 5 normal control tissues and performed single‐nucleus RNA sequencing (snRNA‐seq) to comprehensively map the cellular landscape of VMs. We first identified distinct cell subpopulations covering vascular endothelial cells, vascular smooth muscle cells, and immune cells, and compared gene expression levels between VM and normal tissues. Afterward, we conducted weighted gene co‐expression network analysis (hdWGCNA) and constructed the protein–protein interaction (PPI) network to screen critical proliferation‐related genes in VMs. We further analyzed the signaling pathways associated with these candidate genes and carried out subsequent functional validation experiments to explore the biological role of core gene TEK in proliferative vascular endothelial cells (PVECs). Besides, we also analyzed the characteristic pathways of the PVEC subpopulation to clarify its proliferation‐related molecular features.

Results

We found obvious expression differences of genes in various cell subpopulations between VM and normal tissues. Three genes, namely tyrosine protein kinase receptor (TEK), Fms‐like tyrosine kinase 1 (FLT1), and EGF‐like domain multiple 7 (EGFL7), were identified as key proliferation‐related genes with significant upregulation in VM lesions, and these three genes were closely associated with the activation of PI3K/AKT/mTOR, IL6/JAK/STAT3, and TNF‐α/NF‐κB pathways. Functional experimental results showed that TEK knockdown could significantly inhibit proliferative vascular endothelial cell (PVEC) proliferation and promote cell apoptosis, and reverse the abnormal activation of inflammatory pathways. As a vital pathogenic cell subpopulation, PVECs facilitated abnormal vascular proliferation through activating pathways including the G2/M checkpoint and E2F targets.

Conclusions

Collectively, our study systematically elucidated the cellular heterogeneity framework and proliferation mechanisms of limb VMs, identifying TEK, FLT1, and EGFL7 as key regulators of pathological proliferation. These findings provide new insights into the pathogenesis of VMs and lay a foundation for developing precise therapeutic strategies targeting proliferation‐related pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationVascular MalformationsExtremitiesHumansSignal TransductionEndothelial CellsAnimalsFemaleRNA-SeqMale

Stichwörter der Autor:innen

endothelial cellssingle‐nucleus RNA sequencingvascular smooth muscle cellsvenous malformations

Autor:innen und Institutionen

  • Department of Hemangioma Surgery, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Key Discipline of Hemangioma and Vascular Malformation Medicine in Henan Province, Zhengzhou, Henan, China.
  • Key Laboratory of Hemangioma and Vascular Malformation Medicine in Henan Province, Zhengzhou, Henan, China.
  • Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng, Henan, China.
  • Institute for Sports and Brain Health, School of Physical Education, Henan University, Kaifeng, Henan, China.

ORCID-Profile: Jianshe Wei

Förderung

  • National Natural Science Foundation of China
  • Henan University graduate "Talent Program" of Henan Province of China
  • Henan Natural Science Foundation of China
  • Key Research and Development Project of Henan Province

Zitieren

APA

Lin, J., Liu, T., Fang, B., Feng, X., Jiao, W., Chen, C., Ding, Y., Zhu, G., Wang, W., Liu, W., Li, Y., Hou, S., Wei, J., & Qiao, J. (2026). SnRNA ‐seq reveals cellular heterogeneity and proliferation mechanisms in limb venous malformations. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70256

Vancouver

Lin J, Liu T, Fang B, Feng X, Jiao W, Chen C, et al. SnRNA ‐seq reveals cellular heterogeneity and proliferation mechanisms in limb venous malformations. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70256

BibTeX
@article{Lin2026,
  author = {Lin, Junjie and Liu, Tingting and Fang, Bin and Feng, Xiaojuan and Jiao, Wenting and Chen, Changkuan and Ding, Yaqing and Zhu, Gaozan and Wang, Wenqiu and Liu, Wenbo and Li, Yuanqi and Hou, Shoufu and Wei, Jianshe and Qiao, Junbo},
  title = {SnRNA ‐seq reveals cellular heterogeneity and proliferation mechanisms in limb venous malformations},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  doi = {10.1002/ame2.70256}
}
Kostenlos starten →